Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 51 results for "Vivitrol"

Brokerages Expect Alkermes Plc Will Post Earnings of -$0.39 Pe...

Filed Under: Consensus Rating Articles • Market News Equities analysts predict that Alkermes Plc (NASDAQ:ALKS) will announce ($0.39) earnings per share for the current quarter, Zacks reports. Two analysts have issued estimates for Alkermes Plc's ... American Banking News - Forex, 1 day ago

Insider Selling: Alkermes Plc insider Sells $1,307,160.00 in Stock (ALKS)

Alkermes Plc (NASDAQ:ALKS) insider Shane Cooke sold 18,000 shares of the firm's stock in a transaction on Monday, November 23rd. The stock was sold at an average price of $72.62, for a total transaction of $1,307,160.00. Following the completion of ...
 WKRB News1 day ago Insider Selling: Shane Cooke Sells 18,000 Shares of Alkermes Plc Stock (ALKS)  American Banking News - Forex4 days ago James Frates Insider Trade for 10,000 Shares of Alkermes Plc (NASDAQ:ALKS)  Octafinance2 weeks ago Insider Deal: Iain Brown Sold 10,822 Shares of Alkermes Plc (NASDAQ:ALKS)  Octafinance4 weeks ago

Renaissance Ranch Outpatient Offers Medication for Opiate Addiction Treatment

Renaissance Ranch Outpatient offers medication for opiate addiction patients seeking treatment. By giving the right prescription, doctors can promote faster recovery and prevent future relapses. [BOUNTIFUL, UT, 11/27/2015] Renaissance Ranch ...
 Press Release Ping2 days ago

New addiction treatment sought MyDaytonDailyNews

Last year, opioid overdoses took the lives of 1,988 Ohioans, according to the Ohio Department of Health. In Montgomery County, 190 people died from overdoses of heroin, fentanyl or a combination, according to the coroner's office. In Clark County, ...
 NewsListOnline3 days ago

Alkermes plc Short Interest Update

Alkermes plc (NASDAQ:ALKS) has shown a drop of 17.2% or 1,132,946 shares in the short positions. The bets have increased to 5,439,843 shares on November 13,2015 from 6,572,789 shares on October 30,2015. With respect to the floated shares, the shorts ...
 MoneyFlowIndex.org3 days ago Short Interest Update on Alkermes plc  MoneyFlowIndex.org1 month ago

Heroin, opiate addicts parents: Insurance providers bank on children's failures WISC-TV3

. Just a lot of deaths, a lot of families in chaos, Taylor-Powell stated. If we are not receiving the assistance and treatment that's needed, if people aren't taking something seriously, no it's contributing to the epidemic? As Wisconsin ...
 NewsListOnline5 days ago

The least you need to know about drug advertising

There's been a lot of chatter this week about the American Medical Assn.'s (AMA) vote to ban the advertising of prescription drugs direct to consumer audiences. Here's the least you need to know. AMA cannot actually do anything about consumer ...
 Behavioral Healthcare Magazine1 week ago

Analysts Recent Ratings Updates for Alkermes Plc (ALKS)

A number of research firms have changed their ratings and price targets for Alkermes Plc (NASDAQ: ALKS): 11/6/2015 Alkermes Plc had its price target raised by analysts at Leerink Swann from $81.00 to $84.00. They now have an outperform rating on ...
 American Banking News - Forex2 weeks ago Alkermes plc Analyst Rating Update  MoneyFlowIndex.org3 weeks ago Alkermes Plc (ALKS) Analysts Recent Ratings Changes  American Banking News - Forex3 weeks ago Analyst Price Target Update on Alkermes plc (NASDAQ:ALKS)  OTC Outlook1 month ago

Chief Justice Minton reports on seminal year for court system

FRANKFORT, Ky. -- Chief Justice John D. Minton Jr. gave the legislature an update on the events, accomplishment and turning points that have made 2015 a seminal year for the state court system during the annual State of the Judiciary address today ...
 U.S. Governor of Kentucky3 weeks ago

Inside Selling: Mark Stejbach Unloaded 18,000 Shares of Alkermes Plc (NASDAQ:ALKS)

Mark Stejbach Insider Sell Transaction Mark Stejbach, Chief Commercial Officer of Alkermes Plc (NASDAQ:ALKS) 72.01 +0.24 0.33% is the insider, we want to tell you for. Mr. Mark submitted a document with the D.C. based-SEC disclosing a trade for ...
 Octafinance3 weeks ago Alkermes Plc insider Mark Stejbach Sells 18,000 Shares (ALKS)  WKRB News3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less